ThisCART22 cells injection
ThisCART22
Phase 1 mab active
Quick answer
ThisCART22 cells injection for B Cell Malignancy is a Phase 1 program (mab) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- First Tracks Biotherapeutics
- Indication
- B Cell Malignancy
- Phase
- Phase 1
- Modality
- mab
- Status
- active